DermTech Operating Income 2017-2024 | DMTKQ

DermTech operating income from 2017 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

DermTech Operating Income 2017-2024 | DMTKQ

DermTech operating income from 2017 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$96B
Cencora (COR)$46.2B
DiDi Global (DIDIY)$23.8B
ICON (ICLR)$18.2B
Natera (NTRA)$15.4B
Avantor (AVTR)$15.2B
Revvity (RVTY)$14.9B
Viatris (VTRS)$13.9B
BioMerieux (BMXMF)$12.8B
Solventum (SOLV)$12.5B
CochLear (CHEOY)$12.3B
Medpace Holdings (MEDP)$9.9B
Charles River Laboratories (CRL)$9.3B
Sonic Healthcare (SKHHY)$8.4B
Doximity (DOCS)$7.9B
HealthEquity (HQY)$7.5B
Bausch + Lomb (BLCO)$7.2B
PACS (PACS)$6.5B
Life Times (LTH)$4.7B
Organon (OGN)$4.7B
Sotera Health (SHC)$4.5B
Surgery Partners (SGRY)$3.7B
BrightSpring Health Services (BTSG)$3B
Concentras Parent (CON)$2.5B
Ardent Health Partners (ARDT)$2.5B
Alignment Healthcare (ALHC)$2.5B
GoodRx Holdings (GDRX)$2.3B
GeneDx Holdings (WGS)$2.1B
Premier (PINC)$2B
Ryman Healthcare (RYHTY)$1.9B